Printer Friendly

!C O R R E C T I O N -- VERTEX INDUSTRIES!

 In NY003, Vertex Industries Reports Increased Income, Sales For Second Quarter: Company Issues Statement On Significant Operations During The Period, moved earlier today, we are advised by a representative of the company that the last paragraph, second line, should read "liabilities of its 57 percent-owned Computer Transceiver Systems, Inc." rather than "Computer Technology Systems" as originally issued.
 -0- 3/16/93 C NY003
 /PRNewswire -- March 16/


CO: Vertex Industries, Inc. ST: New Jersey IN: CPR SU: ERN

WB -- NY003A -- 6478 03/16/93 11:01 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 16, 1993
Words:86
Previous Article:DIGITAL EQUIPMENT CORPORATION ANNOUNCES ALPHA AXP SECOND SOURCE RELATIONSHIP WITH MITSUBISHI ELECTRIC CORPORATION
Next Article:ZDS ANNOUNCES ENHANCEMENTS TO POPULAR Z-300/400 SERIES
Topics:


Related Articles
VERTEX INDUSTRIES REPORTS OPERATING RESULTS FOR FISCAL YEAR ENDED JULY 31, 1991
CONVERGENT SOLUTIONS RELEASES CS/ADS 6.4 DATABASE INDEPENDENT 4GL WITH INTERFACE TO INFORMIX
VERTEX INDUSTRIES BEGINS SHIPPING SYSTEMS FOR CONTROL AND MONITORING OF STUDENT ENTRANCE TO NEW YORK CITY HIGH SCHOOLS
IBM OS/2 2.0 SWEEPS TRIPLE CROWN OF PC INDUSTRY
VERTEX INDUSTRIES, INC. SPLITS STOCK 2 FOR 1
IBM AND MULTI SOFT SIGN SOFTWARE MARKETING AGREEMENT
DCA ANNOUNCES SELECT COMM SERVER WITH PC ROUTER SUPPORT
DDH Releases Mobile TS on PalmGear.com; First Palm Application With the Ability to Connect to Windows Terminal Servers.
Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows.
Safety and efficacy of two preparations of megestrol acetate in HIV-infected individuals with weight loss in Africa, India, and the United States.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters